Tag: NeonMind

StaffMarch 22, 2022
shutterstock_1348453088.jpg

2min00
NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF) has filed a new patent application with the United States Patent and Trademark Office (USPTO) related to a novel mechanism of weight loss targeted to specific fat subtypes. The provisional patent application includes data derived from NeonMind’s recent preclinical animal study, incorporating novel findings which indicate, in addition to reiterating weight modulation […]

Kaitlin DomangueMarch 2, 2021
Daily-Hit-Header.png

10min00
It’s time for your Daily Hit of cannabis financial news for March 2nd, 2021.  On the Site Collecting and Storing Cannabis Pollen Most growers these days are only interested in female plants, but if you want to cross different strains and breed new combinations, you’ll need the pollen. And in fact, few companies sell pollen […]

StaffJanuary 27, 2021
Psychedelica.jpg

4min00
Mydecine Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF)  has submitted a formal application to list its common shares on the NASDAQ Stock Exchange. NASDAQ is the second-largest exchange by market capitalization worldwide and is home to many of the world’s best technology companies. “We believe the Company is entering an accelerated growth phase and the […]

StaffJanuary 4, 2021
mushroom5.jpg

3min02
NeonMind Biosciences Inc. (CSE: NEON) common shares have begun trading on the Canadian Securities Exchange under the ticker symbol “NEON”.  NeonMind is a psychedelic drug development company and the company recently completed its oversubscribed Initial Public Offering on December 30, 2020, for gross proceeds of $4.6 million. “Our public listing is a significant milestone for […]

StaffSeptember 30, 2020
Psilocybin.jpg

5min00
Better Plant Sciences Inc.  (OTCQB: VEGGF) that its majority-owned subsidiary NeonMind Biosciences has entered into a definitive agreement with Psygen Labs Inc. for the supply of psilocybin for NeonMind’s planned preclinical, and clinical trials to study the use of a drug product including Psilocybin for the treatment of food cravings and anxiety. The agreement was […]

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.

 Sign up


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.